Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by CohBar, Inc. CohBar, Inc.: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (Form 8-K) November 27, 2023 From CohBar, Inc. Via Business Wire Tickers CWBR CohBar Reports Second Quarter 2023 Financial Results August 14, 2023 From CohBar, Inc. Via GlobeNewswire Tickers CWBR Morphogenesis, Inc. and CohBar, Inc. Announce Positive Results from Phase 1b Trial of IFx-Hu2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC) June 05, 2023 From CohBar, Inc. Via GlobeNewswire Tickers CWBR CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy May 23, 2023 From CohBar, Inc. Via GlobeNewswire Tickers CWBR CohBar Reports Third Quarter 2022 Financial Results and Highlights Recent Corporate Progress November 08, 2022 From CohBar, Inc. Via GlobeNewswire Tickers CWBR CohBar to Announce 2022 Third Quarter Financial Results and Provide Business Update on November 8, 2022 October 26, 2022 From CohBar, Inc. Via GlobeNewswire Tickers CWBR Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
